Reduced Monocyte and Neutrophil Infiltration and Activation by P-Selectin/CD62P Inhibition Enhances Thrombus Resolution.

fibrinolysis monocytes neutrophils tissue factor venous thrombus resolution

Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
22 Feb 2024
Historique:
medline: 22 2 2024
pubmed: 22 2 2024
entrez: 22 2 2024
Statut: aheadofprint

Résumé

Venous thromboembolism is a major health problem. After thrombus formation, its resolution is essential to re-establish blood flow, which is crucially mediated by infiltrating neutrophils and monocytes in concert with activated platelets and endothelial cells. Thus, we aimed to modulate leukocyte function during thrombus resolution post-thrombus formation by blocking P-selectin/CD62P-mediated cell interactions. Thrombosis was induced by inferior vena cava stenosis through ligation in mice. After 1 day, a P-selectin-blocking antibody or isotype control was administered and thrombus composition and resolution were analyzed. Localizing neutrophils and macrophages in thrombotic lesions of wild-type mice revealed that these cells enter the thrombus and vessel wall from the caudal end. Neutrophils were predominantly present 1 day and monocytes/macrophages 3 days after vessel ligation. Blocking P-selectin reduced circulating platelet-neutrophil and platelet-Ly6C Inhibition of P-selectin-dependent activation of monocytes and neutrophils accelerates venous thrombosis resolution due to reduced infiltration and activation of innate immune cells at the site of thrombus formation, which prevents early thrombus stabilization and facilitates fibrinolysis.

Sections du résumé

BACKGROUND UNASSIGNED
Venous thromboembolism is a major health problem. After thrombus formation, its resolution is essential to re-establish blood flow, which is crucially mediated by infiltrating neutrophils and monocytes in concert with activated platelets and endothelial cells. Thus, we aimed to modulate leukocyte function during thrombus resolution post-thrombus formation by blocking P-selectin/CD62P-mediated cell interactions.
METHODS UNASSIGNED
Thrombosis was induced by inferior vena cava stenosis through ligation in mice. After 1 day, a P-selectin-blocking antibody or isotype control was administered and thrombus composition and resolution were analyzed.
RESULTS UNASSIGNED
Localizing neutrophils and macrophages in thrombotic lesions of wild-type mice revealed that these cells enter the thrombus and vessel wall from the caudal end. Neutrophils were predominantly present 1 day and monocytes/macrophages 3 days after vessel ligation. Blocking P-selectin reduced circulating platelet-neutrophil and platelet-Ly6C
CONCLUSIONS UNASSIGNED
Inhibition of P-selectin-dependent activation of monocytes and neutrophils accelerates venous thrombosis resolution due to reduced infiltration and activation of innate immune cells at the site of thrombus formation, which prevents early thrombus stabilization and facilitates fibrinolysis.

Identifiants

pubmed: 38385292
doi: 10.1161/ATVBAHA.123.320016
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Julia B Kral-Pointner (JB)

Ludwig Boltzmann Institute for Cardiovascular Research, Medical University of Vienna, Austria. (J.B.K.-P., P.L.S., K.H.S., A.K., R.S., K.H., H.B., B.K.P., J.W., P. Hohensinner).
Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Austria. (J.B.K.-P., P. Haider, M.S., M.B., C.K., C.H., J.W.).

Patrick Haider (P)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Austria. (J.B.K.-P., P. Haider, M.S., M.B., C.K., C.H., J.W.).

Petra L Szabo (PL)

Ludwig Boltzmann Institute for Cardiovascular Research, Medical University of Vienna, Austria. (J.B.K.-P., P.L.S., K.H.S., A.K., R.S., K.H., H.B., B.K.P., J.W., P. Hohensinner).
Centre for Biomedical Research and Translational Surgery, Medical University of Vienna, Austria. (P.L.S., K.H.S., A.K., H.B., B.K.P., P. Hohensinner).

Manuel Salzmann (M)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Austria. (J.B.K.-P., P. Haider, M.S., M.B., C.K., C.H., J.W.).

Mira Brekalo (M)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Austria. (J.B.K.-P., P. Haider, M.S., M.B., C.K., C.H., J.W.).

Karl H Schneider (KH)

Ludwig Boltzmann Institute for Cardiovascular Research, Medical University of Vienna, Austria. (J.B.K.-P., P.L.S., K.H.S., A.K., R.S., K.H., H.B., B.K.P., J.W., P. Hohensinner).
Centre for Biomedical Research and Translational Surgery, Medical University of Vienna, Austria. (P.L.S., K.H.S., A.K., H.B., B.K.P., P. Hohensinner).

Waltraud C Schrottmaier (WC)

Institute for Vascular Biology and Thrombosis Research, Medical University of Vienna, Austria. (W.C.S., A.A.).

Christoph Kaun (C)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Austria. (J.B.K.-P., P. Haider, M.S., M.B., C.K., C.H., J.W.).

Sonja Bleichert (S)

Division of Vascular Surgery, Department of General Surgery, Medical University of Vienna, Austria. (S.B., C.B.).

Attila Kiss (A)

Ludwig Boltzmann Institute for Cardiovascular Research, Medical University of Vienna, Austria. (J.B.K.-P., P.L.S., K.H.S., A.K., R.S., K.H., H.B., B.K.P., J.W., P. Hohensinner).
Centre for Biomedical Research and Translational Surgery, Medical University of Vienna, Austria. (P.L.S., K.H.S., A.K., H.B., B.K.P., P. Hohensinner).

Romana Sickha (R)

Ludwig Boltzmann Institute for Cardiovascular Research, Medical University of Vienna, Austria. (J.B.K.-P., P.L.S., K.H.S., A.K., R.S., K.H., H.B., B.K.P., J.W., P. Hohensinner).

Christian Hengstenberg (C)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Austria. (J.B.K.-P., P. Haider, M.S., M.B., C.K., C.H., J.W.).

Kurt Huber (K)

Ludwig Boltzmann Institute for Cardiovascular Research, Medical University of Vienna, Austria. (J.B.K.-P., P.L.S., K.H.S., A.K., R.S., K.H., H.B., B.K.P., J.W., P. Hohensinner).
Department of Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria (K.H.).

Christine Brostjan (C)

Division of Vascular Surgery, Department of General Surgery, Medical University of Vienna, Austria. (S.B., C.B.).

Helga Bergmeister (H)

Ludwig Boltzmann Institute for Cardiovascular Research, Medical University of Vienna, Austria. (J.B.K.-P., P.L.S., K.H.S., A.K., R.S., K.H., H.B., B.K.P., J.W., P. Hohensinner).
Centre for Biomedical Research and Translational Surgery, Medical University of Vienna, Austria. (P.L.S., K.H.S., A.K., H.B., B.K.P., P. Hohensinner).

Alice Assinger (A)

Institute for Vascular Biology and Thrombosis Research, Medical University of Vienna, Austria. (W.C.S., A.A.).

Bruno K Podesser (BK)

Ludwig Boltzmann Institute for Cardiovascular Research, Medical University of Vienna, Austria. (J.B.K.-P., P.L.S., K.H.S., A.K., R.S., K.H., H.B., B.K.P., J.W., P. Hohensinner).
Centre for Biomedical Research and Translational Surgery, Medical University of Vienna, Austria. (P.L.S., K.H.S., A.K., H.B., B.K.P., P. Hohensinner).

Johann Wojta (J)

Ludwig Boltzmann Institute for Cardiovascular Research, Medical University of Vienna, Austria. (J.B.K.-P., P.L.S., K.H.S., A.K., R.S., K.H., H.B., B.K.P., J.W., P. Hohensinner).
Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Austria. (J.B.K.-P., P. Haider, M.S., M.B., C.K., C.H., J.W.).

Philipp Hohensinner (P)

Ludwig Boltzmann Institute for Cardiovascular Research, Medical University of Vienna, Austria. (J.B.K.-P., P.L.S., K.H.S., A.K., R.S., K.H., H.B., B.K.P., J.W., P. Hohensinner).
Centre for Biomedical Research and Translational Surgery, Medical University of Vienna, Austria. (P.L.S., K.H.S., A.K., H.B., B.K.P., P. Hohensinner).

Classifications MeSH